VascuNex
AI neuro-cardiac diagnostics to reduce stroke-related damage through faster detection.
Health Tech & Life Sciences
Private
Company Overview
Snapshot
Founded in July 2026, VascuNex operates with 1–10 employees. The company is currently in its Pre-Funding stage, focusing on developing its core technology.
Business overview
VascuNex is an early-stage MedTech startup specializing in AI-based neuro-cardiac diagnostics. The company's core technology aims to reduce stroke-related damage through faster detection, focusing on time-critical decision-making in stroke care. VascuNex serves the healthcare industry, operating within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Digital Medical Diagnostics.
Company Intelligence Q&A
- When was VascuNex founded?
- VascuNex was founded in July 2026.
- What is VascuNex's primary focus?
- VascuNex focuses on developing AI-based neuro-cardiac diagnostics to reduce stroke-related damage through faster detection and time-critical decision-making.
- What is the current employee size of VascuNex?
- VascuNex currently has 1–10 employees.
- Where is VascuNex headquartered?
- VascuNex is headquartered in Rehovot, Israel, at 23 Shaul Zilberman Street.